カテゴリ： 世界, 医療/バイオ, QYResearch

脂肪肝治療薬の世界市場2023年：ALD、NAFLD

■ 英語タイトル：Global Fatty Liver Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8759）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8759
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：83
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[脂肪肝治療薬の世界市場2023年：ALD、NAFLD]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は脂肪肝治療薬のグローバル市場について調査・分析し、世界の脂肪肝治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ALD、NAFLD）、用途別セグメント分析（病院、クリニック）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Pfizer、Gilead Sciences、Astra Zenca、Immuron、Novartis、Takeda、Allergan、Intercept Pharmaceuticals、Conatusなどが含まれています。脂肪肝治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、脂肪肝治療薬市場規模を算出する際に考慮しました。

・脂肪肝治療薬市場の概要
- 脂肪肝治療薬の種類別セグメント
- 世界の脂肪肝治療薬市場規模：タイプ別分析（ALD、NAFLD）
- 脂肪肝治療薬の用途別セグメント
- 世界の脂肪肝治療薬市場規模：用途別分析（病院、クリニック）
- 世界の脂肪肝治療薬市場規模予測（2018年-2029年）

・脂肪肝治療薬市場の成長トレンド
- 脂肪肝治療薬の地域別市場規模（2018年-2029年）
- 脂肪肝治療薬市場ダイナミクス
- 脂肪肝治療薬の業界動向
- 脂肪肝治療薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：ALD、NAFLD
- 世界の脂肪肝治療薬のタイプ別市場規模（2018年-2023年）
- 世界の脂肪肝治療薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、クリニック
- 世界の脂肪肝治療薬の用途別市場規模（2018年-2023年）
- 世界の脂肪肝治療薬の用途別市場規模（2024年-2029年）

・脂肪肝治療薬の地域別市場規模
- 北米の脂肪肝治療薬市場規模（2018年-2029年）
- 米国の脂肪肝治療薬市場規模（2018年-2029年）
- ヨーロッパの脂肪肝治療薬市場規模（2018年-2029年）
- アジア太平洋の脂肪肝治療薬市場規模（2018年-2029年）
- 中国の脂肪肝治療薬市場規模（2018年-2029年）
- 日本の脂肪肝治療薬市場規模（2018年-2029年）
- 韓国の脂肪肝治療薬市場規模（2018年-2029年）
- インドの脂肪肝治療薬市場規模（2018年-2029年）
- オーストラリアの脂肪肝治療薬市場規模（2018年-2029年）
- 中南米の脂肪肝治療薬市場規模（2018年-2029年）
- 中東・アフリカの脂肪肝治療薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Pfizer、Gilead Sciences、Astra Zenca、Immuron、Novartis、Takeda、Allergan、Intercept Pharmaceuticals、Conatus

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Fatty Liver Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Fatty Liver Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Fatty Liver Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Fatty Liver Drugs in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Fatty Liver Drugs include Pfizer, Gilead Sciences, Astra Zenca, Immuron, Novartis, Takeda, Allergan, Intercept Pharmaceuticals and Conatus, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fatty Liver Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fatty Liver Drugs.
The Fatty Liver Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Fatty Liver Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fatty Liver Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Pfizer
Gilead Sciences
Astra Zenca
Immuron
Novartis
Takeda
Allergan
Intercept Pharmaceuticals
Conatus
Segment by Type
ALD
NAFLD
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fatty Liver Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fatty Liver Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 ALD
1.2.3 NAFLD
1.3 Market by Application
1.3.1 Global Fatty Liver Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fatty Liver Drugs Market Perspective (2018-2029)
2.2 Fatty Liver Drugs Growth Trends by Region
2.2.1 Global Fatty Liver Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Fatty Liver Drugs Historic Market Size by Region (2018-2023)
2.2.3 Fatty Liver Drugs Forecasted Market Size by Region (2024-2029)
2.3 Fatty Liver Drugs Market Dynamics
2.3.1 Fatty Liver Drugs Industry Trends
2.3.2 Fatty Liver Drugs Market Drivers
2.3.3 Fatty Liver Drugs Market Challenges
2.3.4 Fatty Liver Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fatty Liver Drugs Players by Revenue
3.1.1 Global Top Fatty Liver Drugs Players by Revenue (2018-2023)
3.1.2 Global Fatty Liver Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Fatty Liver Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fatty Liver Drugs Revenue
3.4 Global Fatty Liver Drugs Market Concentration Ratio
3.4.1 Global Fatty Liver Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fatty Liver Drugs Revenue in 2022
3.5 Fatty Liver Drugs Key Players Head office and Area Served
3.6 Key Players Fatty Liver Drugs Product Solution and Service
3.7 Date of Enter into Fatty Liver Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fatty Liver Drugs Breakdown Data by Type
4.1 Global Fatty Liver Drugs Historic Market Size by Type (2018-2023)
4.2 Global Fatty Liver Drugs Forecasted Market Size by Type (2024-2029)
5 Fatty Liver Drugs Breakdown Data by Application
5.1 Global Fatty Liver Drugs Historic Market Size by Application (2018-2023)
5.2 Global Fatty Liver Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Fatty Liver Drugs Market Size (2018-2029)
6.2 North America Fatty Liver Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Fatty Liver Drugs Market Size by Country (2018-2023)
6.4 North America Fatty Liver Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fatty Liver Drugs Market Size (2018-2029)
7.2 Europe Fatty Liver Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Fatty Liver Drugs Market Size by Country (2018-2023)
7.4 Europe Fatty Liver Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fatty Liver Drugs Market Size (2018-2029)
8.2 Asia-Pacific Fatty Liver Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Fatty Liver Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Fatty Liver Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fatty Liver Drugs Market Size (2018-2029)
9.2 Latin America Fatty Liver Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Fatty Liver Drugs Market Size by Country (2018-2023)
9.4 Latin America Fatty Liver Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fatty Liver Drugs Market Size (2018-2029)
10.2 Middle East & Africa Fatty Liver Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Fatty Liver Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Fatty Liver Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Fatty Liver Drugs Introduction
11.1.4 Pfizer Revenue in Fatty Liver Drugs Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Fatty Liver Drugs Introduction
11.2.4 Gilead Sciences Revenue in Fatty Liver Drugs Business (2018-2023)
11.2.5 Gilead Sciences Recent Development
11.3 Astra Zenca
11.3.1 Astra Zenca Company Detail
11.3.2 Astra Zenca Business Overview
11.3.3 Astra Zenca Fatty Liver Drugs Introduction
11.3.4 Astra Zenca Revenue in Fatty Liver Drugs Business (2018-2023)
11.3.5 Astra Zenca Recent Development
11.4 Immuron
11.4.1 Immuron Company Detail
11.4.2 Immuron Business Overview
11.4.3 Immuron Fatty Liver Drugs Introduction
11.4.4 Immuron Revenue in Fatty Liver Drugs Business (2018-2023)
11.4.5 Immuron Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Fatty Liver Drugs Introduction
11.5.4 Novartis Revenue in Fatty Liver Drugs Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Takeda
11.6.1 Takeda Company Detail
11.6.2 Takeda Business Overview
11.6.3 Takeda Fatty Liver Drugs Introduction
11.6.4 Takeda Revenue in Fatty Liver Drugs Business (2018-2023)
11.6.5 Takeda Recent Development
11.7 Allergan
11.7.1 Allergan Company Detail
11.7.2 Allergan Business Overview
11.7.3 Allergan Fatty Liver Drugs Introduction
11.7.4 Allergan Revenue in Fatty Liver Drugs Business (2018-2023)
11.7.5 Allergan Recent Development
11.8 Intercept Pharmaceuticals
11.8.1 Intercept Pharmaceuticals Company Detail
11.8.2 Intercept Pharmaceuticals Business Overview
11.8.3 Intercept Pharmaceuticals Fatty Liver Drugs Introduction
11.8.4 Intercept Pharmaceuticals Revenue in Fatty Liver Drugs Business (2018-2023)
11.8.5 Intercept Pharmaceuticals Recent Development
11.9 Conatus
11.9.1 Conatus Company Detail
11.9.2 Conatus Business Overview
11.9.3 Conatus Fatty Liver Drugs Introduction
11.9.4 Conatus Revenue in Fatty Liver Drugs Business (2018-2023)
11.9.5 Conatus Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Fatty Liver Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of ALD
Table 3. Key Players of NAFLD
Table 4. Global Fatty Liver Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Fatty Liver Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Fatty Liver Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Fatty Liver Drugs Market Share by Region (2018-2023)
Table 8. Global Fatty Liver Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Fatty Liver Drugs Market Share by Region (2024-2029)
Table 10. Fatty Liver Drugs Market Trends
Table 11. Fatty Liver Drugs Market Drivers
Table 12. Fatty Liver Drugs Market Challenges
Table 13. Fatty Liver Drugs Market Restraints
Table 14. Global Fatty Liver Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Fatty Liver Drugs Market Share by Players (2018-2023)
Table 16. Global Top Fatty Liver Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Drugs as of 2022)
Table 17. Ranking of Global Top Fatty Liver Drugs Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Fatty Liver Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fatty Liver Drugs Product Solution and Service
Table 21. Date of Enter into Fatty Liver Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fatty Liver Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Fatty Liver Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global Fatty Liver Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Fatty Liver Drugs Revenue Market Share by Type (2024-2029)
Table 27. Global Fatty Liver Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Fatty Liver Drugs Revenue Market Share by Application (2018-2023)
Table 29. Global Fatty Liver Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Fatty Liver Drugs Revenue Market Share by Application (2024-2029)
Table 31. North America Fatty Liver Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Fatty Liver Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Fatty Liver Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Fatty Liver Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Fatty Liver Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Fatty Liver Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Fatty Liver Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Fatty Liver Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Fatty Liver Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Fatty Liver Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Fatty Liver Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Fatty Liver Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Fatty Liver Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Fatty Liver Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Fatty Liver Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Fatty Liver Drugs Product
Table 49. Pfizer Revenue in Fatty Liver Drugs Business (2018-2023) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Gilead Sciences Company Detail
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences Fatty Liver Drugs Product
Table 54. Gilead Sciences Revenue in Fatty Liver Drugs Business (2018-2023) & (US$ Million)
Table 55. Gilead Sciences Recent Development
Table 56. Astra Zenca Company Detail
Table 57. Astra Zenca Business Overview
Table 58. Astra Zenca Fatty Liver Drugs Product
Table 59. Astra Zenca Revenue in Fatty Liver Drugs Business (2018-2023) & (US$ Million)
Table 60. Astra Zenca Recent Development
Table 61. Immuron Company Detail
Table 62. Immuron Business Overview
Table 63. Immuron Fatty Liver Drugs Product
Table 64. Immuron Revenue in Fatty Liver Drugs Business (2018-2023) & (US$ Million)
Table 65. Immuron Recent Development
Table 66. Novartis Company Detail
Table 67. Novartis Business Overview
Table 68. Novartis Fatty Liver Drugs Product
Table 69. Novartis Revenue in Fatty Liver Drugs Business (2018-2023) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Takeda Company Detail
Table 72. Takeda Business Overview
Table 73. Takeda Fatty Liver Drugs Product
Table 74. Takeda Revenue in Fatty Liver Drugs Business (2018-2023) & (US$ Million)
Table 75. Takeda Recent Development
Table 76. Allergan Company Detail
Table 77. Allergan Business Overview
Table 78. Allergan Fatty Liver Drugs Product
Table 79. Allergan Revenue in Fatty Liver Drugs Business (2018-2023) & (US$ Million)
Table 80. Allergan Recent Development
Table 81. Intercept Pharmaceuticals Company Detail
Table 82. Intercept Pharmaceuticals Business Overview
Table 83. Intercept Pharmaceuticals Fatty Liver Drugs Product
Table 84. Intercept Pharmaceuticals Revenue in Fatty Liver Drugs Business (2018-2023) & (US$ Million)
Table 85. Intercept Pharmaceuticals Recent Development
Table 86. Conatus Company Detail
Table 87. Conatus Business Overview
Table 88. Conatus Fatty Liver Drugs Product
Table 89. Conatus Revenue in Fatty Liver Drugs Business (2018-2023) & (US$ Million)
Table 90. Conatus Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fatty Liver Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Fatty Liver Drugs Market Share by Type: 2022 VS 2029
Figure 3. ALD Features
Figure 4. NAFLD Features
Figure 5. Global Fatty Liver Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Fatty Liver Drugs Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Fatty Liver Drugs Report Years Considered
Figure 10. Global Fatty Liver Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Fatty Liver Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Fatty Liver Drugs Market Share by Region: 2022 VS 2029
Figure 13. Global Fatty Liver Drugs Market Share by Players in 2022
Figure 14. Global Top Fatty Liver Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Drugs as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Fatty Liver Drugs Revenue in 2022
Figure 16. North America Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Fatty Liver Drugs Market Share by Country (2018-2029)
Figure 18. United States Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Fatty Liver Drugs Market Share by Country (2018-2029)
Figure 22. Germany Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Fatty Liver Drugs Market Share by Region (2018-2029)
Figure 30. China Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Fatty Liver Drugs Market Share by Country (2018-2029)
Figure 38. Mexico Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Fatty Liver Drugs Market Share by Country (2018-2029)
Figure 42. Turkey Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Fatty Liver Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in Fatty Liver Drugs Business (2018-2023)
Figure 45. Gilead Sciences Revenue Growth Rate in Fatty Liver Drugs Business (2018-2023)
Figure 46. Astra Zenca Revenue Growth Rate in Fatty Liver Drugs Business (2018-2023)
Figure 47. Immuron Revenue Growth Rate in Fatty Liver Drugs Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Fatty Liver Drugs Business (2018-2023)
Figure 49. Takeda Revenue Growth Rate in Fatty Liver Drugs Business (2018-2023)
Figure 50. Allergan Revenue Growth Rate in Fatty Liver Drugs Business (2018-2023)
Figure 51. Intercept Pharmaceuticals Revenue Growth Rate in Fatty Liver Drugs Business (2018-2023)
Figure 52. Conatus Revenue Growth Rate in Fatty Liver Drugs Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 脂肪肝治療薬のグローバル市場展望 2023年-2029年：ALD、NAFLD
  • 血液腫瘍薬の世界市場2023年：化学療法、標的療法、免疫療法、その他
  • 高カリウム血症治療薬の世界市場2023年：パティロマー、シクロケイ酸ジルコニウムナトリウム
  • アドレナリン受容体遮断薬の世界市場2023年：アルファブロッカー、ベータブロッカー、その他
  • S1P受容体調節薬の世界市場2023年：フィンゴリモド、オザニモド、シポニモド、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8759 )"脂肪肝治療薬の世界市場2023年：ALD、NAFLD" (英文：Global Fatty Liver Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。